![]() |
Volumn 15, Issue 4, 1997, Pages 513-521
|
Validation of a reversed-phase HPLC method for directly quantifying the enantiomers of MDL 74,156, the primary metabolite of dolasetron mesylate, in human plasmal
|
Author keywords
Direct chiral reversed phase HPLC; Dolasetron mesylate; MDL 74,156; Plasma
|
Indexed keywords
DOLASETRON MESILATE;
HYDRODOLASETRON;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG DETERMINATION;
DRUG STABILITY;
ENANTIOMER;
PRIORITY JOURNAL;
QUALITY CONTROL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG STABILITY;
HUMANS;
INDOLES;
QUINOLIZINES;
REFERENCE STANDARDS;
SEROTONIN ANTAGONISTS;
STEREOISOMERISM;
|
EID: 0031060573
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/S0731-7085(96)01827-4 Document Type: Article |
Times cited : (16)
|
References (13)
|